Literature DB >> 33396563

How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.

Zhongyan Wang1, Megan Snyder2, Jessica E Kenison3, Kangkang Yang1, Brian Lara4, Emily Lydell1, Kawtar Bennani4, Olga Novikov5, Anthony Federico6, Stefano Monti6, David H Sherr1.   

Abstract

For decades, the aryl hydrocarbon receptor (AHR) was studied for its role in environmental chemical toxicity i.e., as a quirk of nature and a mediator of unintended consequences of human pollution. During that period, it was not certain that the AHR had a "normal" physiological function. However, the ongoing accumulation of data from an ever-expanding variety of studies on cancer, cancer immunity, autoimmunity, organ development, and other areas bears witness to a staggering array of AHR-controlled normal and pathological activities. The objective of this review is to discuss how the AHR has gone from a likely contributor to genotoxic environmental carcinogen-induced cancer to a master regulator of malignant cell progression and cancer aggression. Particular focus is placed on the association between AHR activity and poor cancer outcomes, feedback loops that control chronic AHR activity in cancer, and the role of chronically active AHR in driving cancer cell invasion, migration, cancer stem cell characteristics, and survival.

Entities:  

Keywords:  AHR; aryl hydrocarbon receptor; cancer; kynurenine pathway

Mesh:

Substances:

Year:  2020        PMID: 33396563      PMCID: PMC7795223          DOI: 10.3390/ijms22010387

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  224 in total

1.  Prognostic value of nuclear translocation of aryl hydrocarbon receptor for non-small cell lung cancer.

Authors:  Jang-Ming Su; Pinpin Lin; Han Chang
Journal:  Anticancer Res       Date:  2013-09       Impact factor: 2.480

2.  Dioxin receptor is a ligand-dependent E3 ubiquitin ligase.

Authors:  Fumiaki Ohtake; Atsushi Baba; Ichiro Takada; Maiko Okada; Kei Iwasaki; Hiromi Miki; Sayuri Takahashi; Alexander Kouzmenko; Keiko Nohara; Tomoki Chiba; Yoshiaki Fujii-Kuriyama; Shigeaki Kato
Journal:  Nature       Date:  2007-03-29       Impact factor: 49.962

3.  Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.

Authors:  Nam Trung Nguyen; Akihiro Kimura; Taisuke Nakahama; Ichino Chinen; Kazuya Masuda; Keiko Nohara; Yoshiaki Fujii-Kuriyama; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

4.  Role of AhR in regulating cancer stem cell-like characteristics in choriocarcinoma.

Authors:  Chenchun Wu; Shuran Yu; Qianxia Tan; Peng Guo; Huining Liu
Journal:  Cell Cycle       Date:  2018-10-18       Impact factor: 4.534

5.  Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity.

Authors:  Mattias Oberg; Linda Bergander; Helen Håkansson; Ulf Rannug; Agneta Rannug
Journal:  Toxicol Sci       Date:  2005-03-23       Impact factor: 4.849

6.  The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.

Authors:  D W Kim; L Gazourian; S A Quadri; R Romieu-Mourez; D H Sherr; G E Sonenshein
Journal:  Oncogene       Date:  2000-11-16       Impact factor: 9.867

7.  [IARC revision on dioxin and some dioxin-like compounds].

Authors:  S Catalani
Journal:  G Ital Med Lav Ergon       Date:  2010 Jan-Mar

8.  The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Authors:  Jennifer C Schroeder; Brett C Dinatale; Iain A Murray; Colin A Flaveny; Qiang Liu; Elizabeth M Laurenzana; Jyh Ming Lin; Stephen C Strom; Curtis J Omiecinski; Shantu Amin; Gary H Perdew
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

Review 9.  Aryl hydrocarbon receptors: diversity and evolution.

Authors:  Mark E Hahn
Journal:  Chem Biol Interact       Date:  2002-09-20       Impact factor: 5.192

Review 10.  Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers.

Authors:  Takanori Hidaka; Taku Fujimura; Setsuya Aiba
Journal:  Front Med (Lausanne)       Date:  2019-09-04
View more
  8 in total

1.  Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer.

Authors:  Ewart Kuijk; Edwin Cuppen; Judith M Vlaar; Anouska Borgman; Eric Kalkhoven; Denise Westland; Nicolle Besselink; Charles Shale; Bishoy M Faltas; Peter Priestley
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

2.  Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis.

Authors:  Kuo-Min Su; Hong-Wei Gao; Chia-Ming Chang; Kai-Hsi Lu; Mu-Hsien Yu; Yi-Hsin Lin; Li-Chun Liu; Chia-Ching Chang; Yao-Feng Li; Cheng-Chang Chang
Journal:  Biomedicines       Date:  2021-07-22

Review 3.  Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms.

Authors:  Mengsi Hu; Qianhui Wang; Bing Liu; Qiqi Ma; Tingwei Zhang; Tongtong Huang; Zhimei Lv; Rong Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-18

Review 4.  The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated.

Authors:  Roumaïssa Gouasmi; Carole Ferraro-Peyret; Stéphane Nancey; Isabelle Coste; Toufic Renno; Cédric Chaveroux; Nicolas Aznar; Stéphane Ansieau
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

5.  The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation.

Authors:  Jessica E Kenison; Zhongyan Wang; Kangkang Yang; Megan Snyder; Francisco J Quintana; David H Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 6.  Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer.

Authors:  Francisco Alejandro Lagunas-Rangel; Jenni Viivi Linnea-Niemi; Błażej Kudłak; Michael J Williams; Jörgen Jönsson; Helgi B Schiöth
Journal:  Geohealth       Date:  2022-04-01

Review 7.  Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy.

Authors:  Marco Gargaro; Giorgia Manni; Giulia Scalisi; Paolo Puccetti; Francesca Fallarino
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells.

Authors:  Paul R Hollis; Robert J Mobley; Jyoti Bhuju; Amy N Abell; Carrie Hayes Sutter; Thomas R Sutter
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.